ArticleFrontiers in cardiovascular medicine2022
Commentary: SGLT2is vs. GLP1RAs reduce cardiovascular and all-cause mortality.
Lixin Du et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleFrontiers in cardiovascular medicine2022
Lixin Du et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.